Our observation that ε-ACA and carboxypeptidase B, two treatments that are known to block plasminogen binding to the cell surface [42, 43] resulted in the total loss of RAS-dependent plasmin generation by several cancer cell lines is a paradigm shift in that it establishes that plasminogen receptors are necessary for plasmin generation by RAS-transformed cancer cells. This evidence concerns the gene PLG and cancer.